fluorobenzenes has been researched along with Muscular Weakness in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dorajoo, Rs; Gopalakrishnakone, P; Lee, E; Leong, CC; Pereira, BP; Wee, A; Yu, Z | 1 |
| de Carvalho, M; Evangelista, T; Ferro, J; Pereira, P | 1 |
| Bruckert, E; Dallongeville, J; Rosenbaum, D; Sabouret, P | 1 |
| Chao, CY; Lee-Chen, GJ; Shih, CC; Wu, YR | 1 |
4 other study(ies) available for fluorobenzenes and Muscular Weakness
| Article | Year |
|---|---|
Role of multi-drug resistance-associated protein-1 transporter in statin-induced myopathy.
Topics: Animals; Body Weight; Electron Transport Complex IV; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Microscopy, Electron, Transmission; Mitochondria, Muscle; Multidrug Resistance-Associated Proteins; Muscle Weakness; Muscle, Skeletal; Muscular Diseases; Paraffin Embedding; Probenecid; Pyrimidines; Rats; Rats, Sprague-Dawley; Renal Agents; Rosuvastatin Calcium; Sulfonamides | 2008 |
A case of asymptomatic cytoplasmic body myopathy revealed by sinvastatin.
Topics: Aged; Biopsy; Creatine Kinase; Cytoplasm; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inclusion Bodies; Male; Muscle Weakness; Muscle, Skeletal; Muscular Diseases; Necrosis; Pain; Pyrimidines; Rhabdomyolysis; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2009 |
Discontinuation of statin therapy due to muscular side effects: a survey in real life.
Topics: Adult; Aged; Atorvastatin; Dose-Response Relationship, Drug; Female; Fluorobenzenes; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Motor Activity; Muscle Cramp; Muscle Weakness; Muscle, Skeletal; Musculoskeletal Diseases; Pain; Pyrimidines; Pyrroles; Risk Factors; Rosuvastatin Calcium; Simvastatin; Sulfonamides; Surveys and Questionnaires; Treatment Outcome | 2013 |
Effect of statin treatment on adrenomyeloneuropathy with cerebral inflammation: a revisit.
Topics: Adrenoleukodystrophy; Anti-Inflammatory Agents; ATP Binding Cassette Transporter, Subfamily D, Member 1; ATP-Binding Cassette Transporters; Cholesterol, Dietary; Cortisone; Diffusion Magnetic Resonance Imaging; DNA; Encephalitis; Fatty Acids; Fluorobenzenes; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Muscle Weakness; Neurologic Examination; Pyrimidines; Rosuvastatin Calcium; Spinal Cord; Sulfonamides | 2013 |